Prognostic Value of CD74 and HLA-DR Expressions in Invasive Ductal Breast Cancer

作者: Muhittin Yaprak , Gülgün Erdogan , Gulbin Aricic , Barıs Ozcan , Ayhan Mesci

DOI: 10.4236/ABCR.2015.43008

关键词:

摘要: Introduction: Despite the presence of many prognostic and predictive factors, overtreatment remains a major problem in patients with breast cancer. The aim this study is to investigate effects CD74 HLA-DR expressions on prognosis who have had mastectomy for the treatment cancer. Materials Methods: A retrospective search of medical records was carried out surgery cancer at Department General Surgery, Akdeniz University School Medicine, between March 1984 November 1999. Patients regular follow-up and necessary data (i.e. patients’ demographics, pathology results, treatment characteristics) were included study. Paraffin blocks tumor specimens were re-examined with immunohistochemical methods 2010 determine extent and HLA-DR expression level infiltrating lymphocyte (TILs). Results: The mean age median duration 41 participants 48.29 ± 11.86 years 125 months (range 115 135 months), respectively. Disease-free survival (DFS) negative subjects better than positive patients, but difference not statistically significant (p = 0.75). Similarly, HLA-DR groups showed no statistically significant differences terms DFS 0.81). Conclusion: There insignificant correlations increased expression CD74, decreased HLA-DR, TILs levels. Further studies involving larger sample sizes may provide more insight into these associations.

参考文章(10)
Zhong Jiang, Minzhen Xu, Louis Savas, Paula LeClair, B. F. Banner, Invariant chain expression in colon neoplasms. Virchows Archiv. ,vol. 435, pp. 32- 36 ,(1999) , 10.1007/S004280050391
Deepa S. Subramaniam, Claudine Isaacs, Utilizing prognostic and predictive factors in breast cancer. Current Treatment Options in Oncology. ,vol. 6, pp. 147- 159 ,(2005) , 10.1007/S11864-005-0022-1
Ying-Xia Zheng, Ming Yang, Ting-Ting Rong, Xiang-Liang Yuan, Yan-Hui Ma, Zhi-Hao Wang, Li-Song Shen, Long Cui, None, CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer World Journal of Gastroenterology. ,vol. 18, pp. 2253- 2261 ,(2012) , 10.3748/WJG.V18.I18.2253
Shigenori Nagata, Yu-Fen Jin, Katsuhiko Yoshizato, Miki Tomoeda, Misa Song, Norishige Iizuka, Masanori Kitamura, Hidenori Takahashi, Hidetoshi Eguchi, Hiroaki Ohigashi, Osamu Ishikawa, Yasuhiko Tomita, CD74 Is a Novel Prognostic Factor for Patients with Pancreatic Cancer Receiving Multimodal Therapy Annals of Surgical Oncology. ,vol. 16, pp. 2531- 2538 ,(2009) , 10.1245/S10434-009-0532-3
Marion T Weigel, Mitch Dowsett, Current and emerging biomarkers in breast cancer: prognosis and prediction Endocrine-related Cancer. ,vol. 17, ,(2010) , 10.1677/ERC-10-0136
Sumiya Ishigami, Shoji Natsugoe, Koki Tokuda, Akihiro Nakajo, Hirohumi Iwashige, Kuniaki Aridome, Shuichi Hokita, Takashi Aikou, Invariant chain expression in gastric cancer Cancer Letters. ,vol. 168, pp. 87- 91 ,(2001) , 10.1016/S0304-3835(01)00503-1
E. Senkus, S. Kyriakides, F. Penault-Llorca, P. Poortmans, A. Thompson, S. Zackrisson, F. Cardoso, Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of Oncology. ,vol. 24, pp. 1194- 1220 ,(2019) , 10.1093/ANNONC/MDT284
Xuede Lin, Xiaojian Wang, Haley L. Capek, Laura C. Simone, Amit Tuli, Chantey R. Morris, Adrian J. Reber, Joyce C. Solheim, Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines Cancer Immunology, Immunotherapy. ,vol. 58, pp. 729- 736 ,(2009) , 10.1007/S00262-008-0595-1
M Knauer, F Cardoso, J Wesseling, PL Bedard, SC Linn, EJT Rutgers, LJ Van't Veer, None, Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature British Journal of Cancer. ,vol. 103, pp. 1788- 1793 ,(2010) , 10.1038/SJ.BJC.6605916